PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsFenamole
Fenamole
Fenamole is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
0.025% capsaicin pain relief patchC2002632025-03-05
0.025% capsaicin patch (2 patches/pouch) 3% menthol plus 0.083% capsaicin pain relief patch (2 patches/pouch) 5% menthol pain relief patch (1 lar...C2002632024-08-15
0.025% capsaicin patch 4% lidocaine pain relief patch 4% lidocaine plus 1% menthol pain relief patch 5% menthol pain relief patchC2002632024-06-13
10% methyl salicylate pain relief patchC2002632024-06-27
2-count heat patchesC2002632024-12-19
4% lidocaine pain relief patchC2002632025-03-05
4% lidocaine plus 1% menthol pain relief patchC2002632025-03-05
5% menthol pain relief patchC2002632025-03-05
absorbine jr back patchC2002632024-09-25
absorbine jr. pain relieving knee patchC2002632024-09-25
Show 486 more
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
218 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Atopic dermatitisD003876EFO_0000274L20———1—1
EczemaD004485—L30.9———1—1
DermatitisD003872—L30.9———1—1
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Heart failureD006333EFO_0003144I50————11
Diabetic nephropathiesD003928EFO_0000401—————11
HypertensionD006973EFO_0000537I10————11
Pulmonary hypertensionD006976EFO_0001361I27.20————11
Kidney diseasesD007674EFO_0003086N08————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameFenamole
INNfenamole
Description
Fenamole is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Nc1nnnn1-c1ccccc1
Identifiers
PDB—
CAS-ID5467-78-7
RxCUI—
ChEMBL IDCHEMBL2106224
ChEBI ID—
PubChem CID—
DrugBank—
UNII IDK4H264PBQ7 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 51,609 documents
View more details
Safety
Black-box Warning
Black-box warning for: Diclovix m
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
313,155 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use